SARS‐CoV‐2 infection in hematological patients during allogenic stem cell transplantation: A double case report

Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.

Detalles Bibliográficos
Autores principales: Alexandra, Van Uytvanck, Sebastian, Wittnebel, Nathalie, Meuleman, Angela, Loizidou, Jean‐Corentin, Salengros, Chloé, Spilleboudt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8287311/
https://www.ncbi.nlm.nih.gov/pubmed/34295477
http://dx.doi.org/10.1002/ccr3.4439
Descripción
Sumario:Despite severe immunosuppression due to conditioning chemotherapy for acute myeloid leukemia, COVID‐19 did not lead to clinical deterioration or death, thus raising the question of the impact of immunosuppressive treatment on clinical course evolution.

Ejemplares similares